A detailed history of First Command Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First Command Bank holds 18,003 shares of BMY stock, worth $1.06 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
18,003
Previous 18,548 2.94%
Holding current value
$1.06 Million
Previous $1.29 Million 10.43%
% of portfolio
0.11%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 21, 2023

SELL
$63.71 - $70.74 $34,721 - $38,553
-545 Reduced 2.94%
18,003 $1.15 Million
Q1 2023

Apr 14, 2023

SELL
$65.71 - $74.53 $9,002 - $10,210
-137 Reduced 0.73%
18,548 $1.29 Million
Q2 2022

Jul 21, 2022

SELL
$72.62 - $79.98 $336,811 - $370,947
-4,638 Reduced 19.89%
18,685 $1.44 Million
Q1 2022

Apr 14, 2022

SELL
$61.48 - $73.72 $79,432 - $95,246
-1,292 Reduced 5.25%
23,323 $1.7 Million
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $623,371 - $678,851
10,069 Added 69.22%
24,615 $1.65 Million
Q1 2021

Apr 20, 2021

BUY
$59.34 - $66.74 $711,605 - $800,346
11,992 Added 469.54%
14,546 $918,000
Q4 2020

Jan 19, 2021

SELL
$57.74 - $65.43 $808 - $916
-14 Reduced 0.55%
2,554 $158,000
Q3 2020

Oct 20, 2020

BUY
$57.43 - $63.64 $804 - $890
14 Added 0.55%
2,568 $155,000
Q2 2020

Jul 17, 2020

SELL
$54.82 - $64.09 $5,482 - $6,409
-100 Reduced 3.77%
2,554 $150,000
Q1 2020

Apr 20, 2020

SELL
$46.4 - $67.43 $16,008 - $23,263
-345 Reduced 11.5%
2,654 $148,000
Q4 2019

Jan 14, 2020

BUY
$49.21 - $64.19 $49,062 - $63,997
997 Added 49.8%
2,999 $192,000
Q2 2019

Jul 11, 2019

SELL
$44.62 - $49.34 $4,462 - $4,934
-100 Reduced 4.76%
2,002 $91,000
Q2 2018

Jul 20, 2018

SELL
$50.53 - $62.98 $25,265 - $31,490
-500 Reduced 19.22%
2,102 $116,000
Q1 2018

Apr 12, 2018

SELL
$59.92 - $68.98 $23,968 - $27,592
-400 Reduced 13.32%
2,602 $0
Q3 2017

Oct 10, 2017

BUY
$55.23 - $63.74 $165,800 - $191,347
3,002
3,002 $192,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First Command Bank Portfolio

Follow First Command Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Command Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Command Bank with notifications on news.